Global Diagnostic Technology Market Overview:
Identification of a disease, condition, disorder, or problem by systematic analysis of the background or history, examination of the signs or symptoms, evaluation of the research or test results, and investigation of the assumed or probable causes. Effective prognosis is not possible without an effective diagnosis. Diagnostic technology has been proven as the most effective technology in the field of healthcare and gained significant importance across the globe. Diagnostic technology has resolved many issues such as data errors, complexities, and other outcomes. It is aiming for escalating the volume of molecular insights and translating it into products with high medical significance for physicians and patients. Some of the key players profiled in the study are Roche Diagnostics SpA (Italy), Danaher Corporation (United States), Abbott Laboratories, Inc. (United States), Siemens AG (United States), Sysmex Corporation (Japan), Thermo Fisher Scientific (United States), Becton, Dickinson, and Company (United States), Biomérieux SA (France), Bio-Rad Laboratories, Inc. (France) and Johnson & Johnson (United States).
On the basis of geography, the market of Diagnostic Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Hospitals will boost the Diagnostic Technology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising Geriatric Population
- The Rising Prevalence of Infectious and Chronic Diseases
- Growing Awareness of Personalized Medicine
- Increasing Adoption of Point-Of-Care Testing
- Growing Awareness Regarding Preventive Care
- Critical Reimbursement Scenario
- Development of Condition-Specific Markers and Tests
- Growing Importance of Companion Diagnostics
- Emerging Demand from Economies
- Operational Obstacles Faced in Conducting Diagnostic Tests
- Changing Regulatory Landscape
On 3 Aug 2018, Sysmex Corporation and JVCKENWOOD Corporation have reached an agreement to jointly establish a new company, Creative Nanosystems Corporation, to develop and manufacture bio devices. These in vitro diagnostic devices will consist of microfluidics to achieve rapid reactions amongst tiny amounts of specimens and reagents. and On 9 March 2018, Danaher Corp., a leading diagnostic technology firm and Integrated DNA Technologies, have announced a definitive agreement to acquire IDT, a privately-held provider of high-value consumables for genomics applications in molecular biology, next-generation sequencing, qPCR, synthetic biology, gene editing and molecular diagnostics.
Target Audience:Diagnostic Technology Companies, Group Purchase Organizations (GPOs), OEM Manufacturers, Pathologists and Pathology Laboratories, Distributors of IVD Products, Hospitals and Clinics, Healthcare Institutions, Research Institutes, Market Research and Consulting Firms and Venture Capitalists and Investors
Major Objectives Focused through this Study To define, describe, and forecast the Global Diagnostic Technology market on the basis of product [Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis and Other IVD Technologies] , application [Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing/Pharmacogenomics, HIV/Aids and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Diagnostic Technology market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Diagnostic Technology industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Diagnostic Technology Pty. Ltd. (Australia), Agilent Technologies (United States), QIAGEN GmbH (Germany), Diasorin S.p.A (Italy) and Ortho Clinical Diagnostics (A Part of Carlyle Group) (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Diagnostic Technology market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.